Innovative Israeli treatment brings new hope to people with paralysis...

Israeli biotech company NurExone is loading exosomes with molecular cargo designed to encourage nerve regeneration. The experimental therapy targets the PTEN protein and is delivered through nasal drops.

In rat studies, animals with completely severed spinal cords regained the ability to walk after treatment. The approach has not yet been tested in humans.